Catalyst Pharmaceuticals, Inc.
Board Member
2026-07-15–present
Board Member
Catalyst Pharmaceuticals, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Enrica Dogali is recorded as Board Member at Catalyst Pharmaceuticals, Inc.. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed July 16, 2026 that Enrica Dogali was appointed director, effective July 15, 2026.
“as of the Effective Time, the directors of Merger Sub immediately prior to the Effective Time (Sergio Marullo di Condojanni; Massimo Marin; Enrica Dogali) became the directors of the Surviving Corporation.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Catalyst Pharmaceuticals, Inc.
Board Member
SEC 8-K
2026-07-15–present
Recorded roles and call appearances connecting this person to public companies.
Catalyst Pharmaceuticals, Inc.
Board Member
2026-07-15–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.